Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Spontaneous Urticaria and Its Association with Serum Interleukin-33 Levels
Authors:
- Carmen-Teodora Dobrican-BăruțaCDCarmen-Teodora Dobrican-Băruța
- Diana Mihaela DeleanuDDDiana Mihaela Deleanu
- Mihaela IancuMihaela Iancu
- Ioana Adriana MunteanIMIoana Adriana Muntean
- Irena NedeleaINIrena Nedelea
- Radu-Gheorghe BălanRBRadu-Gheorghe Bălan
- Lucia Maria ProcopciucLucia Maria Procopciuc
- Gabriela Adriana FilipGabriela Adriana Filip
Open Access
- 22 December 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13709
Abstract
Urticaria is a debilitating skin condition affecting up to 20% of the global population, characterized by erythematous, maculopapular lesions and significant quality of life impairment. This study focused on the role of interleukin 33 (IL-33) and its polymorphisms, particularly SNP rs1929992, in chronic spontaneous urticaria (CSU). Using demographic, clinical, and laboratory data from CSU patients and controls, we estimated allele and genotype frequencies, Hardy–Weinberg equilibrium condition, and serum IL-33 levels, using unconditional binomial logistic regression for association analysis. Results revealed that CSU patients had significantly higher frequencies of the minor allele of IL-33 rs1929992 compared to controls (31.25% vs. 17.35%, p = 0.024), and carriers of the GA genotype exhibited increased odds of CSU (adjusted OR = 2.208, p ≤ 0.001). Additionally, serum IL-33 levels were markedly elevated in CSU patients, particularly those with the GA genotype. The findings suggest that the IL-33 SNP is associated with an increased susceptibility to CSU, emphasizing its potential as a diagnostic and therapeutic biomarker. This study underscores the genetic and immunological underpinnings of CSU, paving the way for personalized treatment approaches.Keywords
All Related Versions
Funding Information
- “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania (2462/18)
This publication has 53 references indexed in Scilit:
- Association of interleukin 33 gene polymorphisms with susceptibility and regulation of inflammatory mediators in Systemic lupus erythematosus patientsClinical Rheumatology, 2023
- Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokineCytokine, 2022
- Autoimmune comorbidity in chronic spontaneous urticaria: A systematic reviewAutoimmunity Reviews, 2017
- The role of the inflammasome in patients with autoinflammatory diseasesJournal of Allergy and Clinical Immunology, 2016
- Interleukin-33 in Tissue Homeostasis, Injury, and InflammationImmunity, 2015
- Chronic Spontaneous UrticariaImmunology and Allergy Clinics of North America, 2014
- A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticariaJournal of Allergy and Clinical Immunology, 2011
- Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseJournal of Allergy and Clinical Immunology, 2011
- Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratioHuman Psychopharmacology: Clinical and Experimental, 2011
- IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated CytokinesImmunity, 2005